Your session is about to expire
← Back to Search
3D Team Care for Dementia
N/A
Recruiting
Led By Richard H Fortinsky, PhD
Research Sponsored by UConn Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Must not have
Bedbound and non-communicative
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test a team care model focused on cognitive vulnerability (the 3Ds) in order to improve outcomes for older adults.
Who is the study for?
This trial is for older adults living at home or in assisted living with dementia, depression, or recent delirium. They should plan to stay local for a year and speak English. It's not for those with schizophrenia/bipolar disorder, bedbound/non-communicative individuals, those expected to live less than a year, or if already in the comparator program.
What is being tested?
The study tests a Home Based Care Team model led by nurse practitioners against regular telephone check-ins. The goal is to see if this approach reduces hospital visits and improves depression symptoms, disability levels, and overall quality of life.
What are the potential side effects?
Since this trial involves care models rather than medications, traditional side effects are not applicable. However, there may be emotional or psychological impacts from receiving different levels of attention and care.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am unable to get out of bed or communicate.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Proportion hospitalized or used emergency department without hospitalization
Secondary study objectives
Caregiver Assessment of Function and Upset (CAFU)
Family caregiver perceived well-being
GRID Hamilton Rating Scale for Depression (GRID-HAMD), 17-item version.
Other study objectives
Center for Epidemiologic Studies-Depression Scale (CES-D)
Neuropsychiatric Inventory (NPI-C)
Quality of Life-Alzheimer's Disease Scale (QOL-AD)
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Home Based Care TeamExperimental Treatment1 Intervention
Primarily in-home treatment provided by team led by nurse practitioner with geriatrics and geriatric psychiatry expertise.
Group II: Telephone Based Care TeamActive Control1 Intervention
Primarily telephone-based treatment provided by existing care management program offered by collaborating Medicare Advantage insurer.
Find a Location
Who is running the clinical trial?
UConn HealthLead Sponsor
212 Previous Clinical Trials
60,222 Total Patients Enrolled
3 Trials studying Dementia
791 Patients Enrolled for Dementia
Patient-Centered Outcomes Research InstituteOTHER
572 Previous Clinical Trials
27,077,025 Total Patients Enrolled
6 Trials studying Dementia
51,774 Patients Enrolled for Dementia
University of ConnecticutOTHER
189 Previous Clinical Trials
160,345 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have been diagnosed with schizophrenia or bipolar disorder.I am unable to get out of bed or communicate.You are expected to live for less than 12 months.I am willing to be randomly placed in a treatment or comparison group.I have been diagnosed with dementia, depression, or delirium.
Research Study Groups:
This trial has the following groups:- Group 1: Home Based Care Team
- Group 2: Telephone Based Care Team
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger